The global Oral Solid Dosage Manufacturing Market growth is projected to reach US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Oral Solid Dosage Manufacturing Market Growth And Outlook 2025-31

The global Oral Solid Dosage Manufacturing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Oral solid dosage manufacturing refers to the process of producing pharmaceutical products in solid form that are intended to be taken orally, such as tablets, capsules, and powders. This manufacturing process involves several steps, including formulation development, blending, granulation, compression, coating, and packaging. Formulation development is the initial stage where the active pharmaceutical ingredient (API) and other excipients are selected and combined to create a stable and effective dosage form. Blending involves mixing the API and excipients to ensure uniform distribution of the drug throughout the dosage form. Granulation is the process of forming granules from the blended mixture to improve flowability and compressibility. Compression is the step where the granules are compressed into tablets or filled into capsules using specialized equipment. Coating may be applied to tablets to improve appearance, taste, and stability, as well as to control the release of the drug. Finally, the finished dosage forms are packaged in appropriate containers, such as blister packs or bottles, and labeled for distribution. Oral solid dosage manufacturing requires strict adherence to Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of the pharmaceutical products. This includes maintaining a controlled manufacturing environment, conducting regular quality control testing, and following standard operating procedures to prevent contamination and ensure consistency in the manufacturing process. United States market for Oral Solid Dosage Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Oral Solid Dosage Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Oral Solid Dosage Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Oral Solid Dosage Manufacturing players cover CRB, LGM Pharma, Pfizer, Piramal Group, Avara Pharmaceutical Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the ?Oral Solid Dosage Manufacturing Industry Forecast? looks at past sales and reviews total world Oral Solid Dosage Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Solid Dosage Manufacturing sales for 2025 through 2031. With Oral Solid Dosage Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Solid Dosage Manufacturing industry. This Insight Report provides a comprehensive analysis of the global Oral Solid Dosage Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Solid Dosage Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oral Solid Dosage Manufacturing market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Solid Dosage Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Solid Dosage Manufacturing. This report presents a comprehensive overview, market shares, and growth opportunities of Oral Solid Dosage Manufacturing market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Wet Granulation &nbsp;&nbsp;&nbsp; Dry Granulation &nbsp;&nbsp;&nbsp; Direct Compression &nbsp;&nbsp;&nbsp; Particle Coating &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Drug Formulation Development &nbsp;&nbsp;&nbsp; Formulation Production This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; CRB &nbsp;&nbsp;&nbsp; LGM Pharma &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Piramal Group &nbsp;&nbsp;&nbsp; Avara Pharmaceutical Services &nbsp;&nbsp;&nbsp; Alcami &nbsp;&nbsp;&nbsp; Thermo Fisher Scientific &nbsp;&nbsp;&nbsp; Recipharm &nbsp;&nbsp;&nbsp; Metrics Contract Services &nbsp;&nbsp;&nbsp; BOC Sciences &nbsp;&nbsp;&nbsp; Societal CDMO &nbsp;&nbsp;&nbsp; DFE Pharma &nbsp;&nbsp;&nbsp; NNE &nbsp;&nbsp;&nbsp; Pharma Access

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Oral Solid Dosage Manufacturing Market Size (2020-2031) &nbsp;2.1.2 Oral Solid Dosage Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Oral Solid Dosage Manufacturing by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Oral Solid Dosage Manufacturing Segment by Type &nbsp;2.2.1 Wet Granulation &nbsp;2.2.2 Dry Granulation &nbsp;2.2.3 Direct Compression &nbsp;2.2.4 Particle Coating &nbsp;2.2.5 Other &nbsp;2.3 Oral Solid Dosage Manufacturing Market Size by Type &nbsp;2.3.1 Oral Solid Dosage Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Oral Solid Dosage Manufacturing Market Size Market Share by Type (2020-2025) &nbsp;2.4 Oral Solid Dosage Manufacturing Segment by Application &nbsp;2.4.1 Drug Formulation Development &nbsp;2.4.2 Formulation Production &nbsp;2.5 Oral Solid Dosage Manufacturing Market Size by Application &nbsp;2.5.1 Oral Solid Dosage Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Oral Solid Dosage Manufacturing Market Size Market Share by Application (2020-2025) 3 Oral Solid Dosage Manufacturing Market Size by Player &nbsp;3.1 Oral Solid Dosage Manufacturing Market Size Market Share by Player &nbsp;3.1.1 Global Oral Solid Dosage Manufacturing Revenue by Player (2020-2025) &nbsp;3.1.2 Global Oral Solid Dosage Manufacturing Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Oral Solid Dosage Manufacturing Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Oral Solid Dosage Manufacturing by Region &nbsp;4.1 Oral Solid Dosage Manufacturing Market Size by Region (2020-2025) &nbsp;4.2 Global Oral Solid Dosage Manufacturing Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Oral Solid Dosage Manufacturing Market Size Growth (2020-2025) &nbsp;4.4 APAC Oral Solid Dosage Manufacturing Market Size Growth (2020-2025) &nbsp;4.5 Europe Oral Solid Dosage Manufacturing Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Oral Solid Dosage Manufacturing Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Oral Solid Dosage Manufacturing Market Size by Country (2020-2025) &nbsp;5.2 Americas Oral Solid Dosage Manufacturing Market Size by Type (2020-2025) &nbsp;5.3 Americas Oral Solid Dosage Manufacturing Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Oral Solid Dosage Manufacturing Market Size by Region (2020-2025) &nbsp;6.2 APAC Oral Solid Dosage Manufacturing Market Size by Type (2020-2025) &nbsp;6.3 APAC Oral Solid Dosage Manufacturing Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Oral Solid Dosage Manufacturing Market Size by Country (2020-2025) &nbsp;7.2 Europe Oral Solid Dosage Manufacturing Market Size by Type (2020-2025) &nbsp;7.3 Europe Oral Solid Dosage Manufacturing Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Oral Solid Dosage Manufacturing by Region (2020-2025) &nbsp;8.2 Middle East & Africa Oral Solid Dosage Manufacturing Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Oral Solid Dosage Manufacturing Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Oral Solid Dosage Manufacturing Market Forecast &nbsp;10.1 Global Oral Solid Dosage Manufacturing Forecast by Region (2026-2031) &nbsp;10.1.1 Global Oral Solid Dosage Manufacturing Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Oral Solid Dosage Manufacturing Forecast &nbsp;10.1.3 APAC Oral Solid Dosage Manufacturing Forecast &nbsp;10.1.4 Europe Oral Solid Dosage Manufacturing Forecast &nbsp;10.1.5 Middle East & Africa Oral Solid Dosage Manufacturing Forecast &nbsp;10.2 Americas Oral Solid Dosage Manufacturing Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.2.2 Canada Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.2.3 Mexico Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.2.4 Brazil Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.3 APAC Oral Solid Dosage Manufacturing Forecast by Region (2026-2031) &nbsp;10.3.1 China Oral Solid Dosage Manufacturing Market Forecast &nbsp;10.3.2 Japan Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.3.3 Korea Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.3.4 Southeast Asia Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.3.5 India Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.3.6 Australia Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.4 Europe Oral Solid Dosage Manufacturing Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.4.2 France Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.4.3 UK Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.4.4 Italy Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.4.5 Russia Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.5 Middle East & Africa Oral Solid Dosage Manufacturing Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.5.2 South Africa Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.5.3 Israel Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.5.4 Turkey Market Oral Solid Dosage Manufacturing Forecast &nbsp;10.6 Global Oral Solid Dosage Manufacturing Forecast by Type (2026-2031) &nbsp;10.7 Global Oral Solid Dosage Manufacturing Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Oral Solid Dosage Manufacturing Forecast 11 Key Players Analysis &nbsp;11.1 CRB &nbsp;11.1.1 CRB Company Information &nbsp;11.1.2 CRB Oral Solid Dosage Manufacturing Product Offered &nbsp;11.1.3 CRB Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 CRB Main Business Overview &nbsp;11.1.5 CRB Latest Developments &nbsp;11.2 LGM Pharma &nbsp;11.2.1 LGM Pharma Company Information &nbsp;11.2.2 LGM Pharma Oral Solid Dosage Manufacturing Product Offered &nbsp;11.2.3 LGM Pharma Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 LGM Pharma Main Business Overview &nbsp;11.2.5 LGM Pharma Latest Developments &nbsp;11.3 Pfizer &nbsp;11.3.1 Pfizer Company Information &nbsp;11.3.2 Pfizer Oral Solid Dosage Manufacturing Product Offered &nbsp;11.3.3 Pfizer Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Pfizer Main Business Overview &nbsp;11.3.5 Pfizer Latest Developments &nbsp;11.4 Piramal Group &nbsp;11.4.1 Piramal Group Company Information &nbsp;11.4.2 Piramal Group Oral Solid Dosage Manufacturing Product Offered &nbsp;11.4.3 Piramal Group Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Piramal Group Main Business Overview &nbsp;11.4.5 Piramal Group Latest Developments &nbsp;11.5 Avara Pharmaceutical Services &nbsp;11.5.1 Avara Pharmaceutical Services Company Information &nbsp;11.5.2 Avara Pharmaceutical Services Oral Solid Dosage Manufacturing Product Offered &nbsp;11.5.3 Avara Pharmaceutical Services Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Avara Pharmaceutical Services Main Business Overview &nbsp;11.5.5 Avara Pharmaceutical Services Latest Developments &nbsp;11.6 Alcami &nbsp;11.6.1 Alcami Company Information &nbsp;11.6.2 Alcami Oral Solid Dosage Manufacturing Product Offered &nbsp;11.6.3 Alcami Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Alcami Main Business Overview &nbsp;11.6.5 Alcami Latest Developments &nbsp;11.7 Thermo Fisher Scientific &nbsp;11.7.1 Thermo Fisher Scientific Company Information &nbsp;11.7.2 Thermo Fisher Scientific Oral Solid Dosage Manufacturing Product Offered &nbsp;11.7.3 Thermo Fisher Scientific Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Thermo Fisher Scientific Main Business Overview &nbsp;11.7.5 Thermo Fisher Scientific Latest Developments &nbsp;11.8 Recipharm &nbsp;11.8.1 Recipharm Company Information &nbsp;11.8.2 Recipharm Oral Solid Dosage Manufacturing Product Offered &nbsp;11.8.3 Recipharm Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Recipharm Main Business Overview &nbsp;11.8.5 Recipharm Latest Developments &nbsp;11.9 Metrics Contract Services &nbsp;11.9.1 Metrics Contract Services Company Information &nbsp;11.9.2 Metrics Contract Services Oral Solid Dosage Manufacturing Product Offered &nbsp;11.9.3 Metrics Contract Services Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Metrics Contract Services Main Business Overview &nbsp;11.9.5 Metrics Contract Services Latest Developments &nbsp;11.10 BOC Sciences &nbsp;11.10.1 BOC Sciences Company Information &nbsp;11.10.2 BOC Sciences Oral Solid Dosage Manufacturing Product Offered &nbsp;11.10.3 BOC Sciences Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 BOC Sciences Main Business Overview &nbsp;11.10.5 BOC Sciences Latest Developments &nbsp;11.11 Societal CDMO &nbsp;11.11.1 Societal CDMO Company Information &nbsp;11.11.2 Societal CDMO Oral Solid Dosage Manufacturing Product Offered &nbsp;11.11.3 Societal CDMO Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Societal CDMO Main Business Overview &nbsp;11.11.5 Societal CDMO Latest Developments &nbsp;11.12 DFE Pharma &nbsp;11.12.1 DFE Pharma Company Information &nbsp;11.12.2 DFE Pharma Oral Solid Dosage Manufacturing Product Offered &nbsp;11.12.3 DFE Pharma Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 DFE Pharma Main Business Overview &nbsp;11.12.5 DFE Pharma Latest Developments &nbsp;11.13 NNE &nbsp;11.13.1 NNE Company Information &nbsp;11.13.2 NNE Oral Solid Dosage Manufacturing Product Offered &nbsp;11.13.3 NNE Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 NNE Main Business Overview &nbsp;11.13.5 NNE Latest Developments &nbsp;11.14 Pharma Access &nbsp;11.14.1 Pharma Access Company Information &nbsp;11.14.2 Pharma Access Oral Solid Dosage Manufacturing Product Offered &nbsp;11.14.3 Pharma Access Oral Solid Dosage Manufacturing Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Pharma Access Main Business Overview &nbsp;11.14.5 Pharma Access Latest Developments 12 Research Findings and Conclusion

Report	Global Oral Solid Dosage Manufacturing Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI9235

Buyer Information

Order Summary